Tracing oncogene-driven remodelling of the intestinal stem cell niche

被引:0
|
作者
Min Kyu Yum
Seungmin Han
Juergen Fink
Szu-Hsien Sam Wu
Catherine Dabrowska
Teodora Trendafilova
Roxana Mustata
Lemonia Chatzeli
Roberta Azzarelli
Irina Pshenichnaya
Eunmin Lee
Frances England
Jong Kyoung Kim
Daniel E. Stange
Anna Philpott
Joo-Hyeon Lee
Bon-Kyoung Koo
Benjamin D. Simons
机构
[1] University of Cambridge,Wellcome Trust–Cancer Research UK Gurdon Institute
[2] University of Cambridge,Wellcome Trust–Medical Research Council Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre
[3] Vienna Biocenter (VBC),Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)
[4] Doctoral School at the University of Vienna and Medical University of Vienna,Vienna BioCenter PhD Program
[5] University of Cambridge,Department of Physiology, Development and Neuroscience
[6] University of Cambridge,Department of Oncology
[7] Hutchison–MRC Research Centre,Department of New Biology
[8] DGIST,Department of Visceral, Thoracic and Vascular Surgery
[9] University Hospital Carl Gustav Carus,Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences
[10] Medical Faculty,undefined
[11] Technische Universität Dresden,undefined
[12] University of Cambridge,undefined
来源
Nature | 2021年 / 594卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interactions between tumour cells and the surrounding microenvironment contribute to tumour progression, metastasis and recurrence1–3. Although mosaic analyses in Drosophila have advanced our understanding of such interactions4,5, it has been difficult to engineer parallel approaches in vertebrates. Here we present an oncogene-associated, multicolour reporter mouse model—the Red2Onco system—that allows differential tracing of mutant and wild-type cells in the same tissue. By applying this system to the small intestine, we show that oncogene-expressing mutant crypts alter the cellular organization of neighbouring wild-type crypts, thereby driving accelerated clonal drift. Crypts that express oncogenic KRAS or PI3K secrete BMP ligands that suppress local stem cell activity, while changes in PDGFRloCD81+ stromal cells induced by crypts with oncogenic PI3K alter the WNT signalling environment. Together, these results show how oncogene-driven paracrine remodelling creates a niche environment that is detrimental to the maintenance of wild-type tissue, promoting field transformation dominated by oncogenic clones.
引用
收藏
页码:442 / 447
页数:5
相关论文
共 50 条
  • [1] Tracing oncogene-driven remodelling of the intestinal stem cell niche
    Yum, Min Kyu
    Han, Seungmin
    Fink, Juergen
    Wu, Szu-Hsien Sam
    Dabrowska, Catherine
    Trendafilova, Teodora
    Mustata, Roxana
    Chatzeli, Lemonia
    Azzarelli, Roberta
    Pshenichnaya, Irina
    Lee, Eunmin
    England, Frances
    Kim, Jong Kyoung
    Stange, Daniel E.
    Philpott, Anna
    Lee, Joo-Hyeon
    Koo, Bon-Kyoung
    Simons, Benjamin D.
    [J]. NATURE, 2021, 594 (7863) : 442 - +
  • [2] Oncogene-Driven Metabolic Alterations in Cancer
    Min, Hye-Young
    Lee, Ho-Young
    [J]. BIOMOLECULES & THERAPEUTICS, 2018, 26 (01) : 45 - 56
  • [3] Inflammation and cancer: The oncogene-driven connection
    Borrello, Maria Grazia
    Degl'Innocenti, Debora
    Pierotti, Marco A.
    [J]. CANCER LETTERS, 2008, 267 (02) : 262 - 270
  • [4] Mediating Resistance in Oncogene-Driven Cancers
    Rosell, Rafael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (16): : 1551 - 1552
  • [5] Oncogene-Driven Hemostatic Changes in Cancer
    Rak, Janusz
    Yu, Joanne
    Milsom, Chloe
    [J]. CANCER INVESTIGATION, 2009, 27 : 28 - 35
  • [6] Treatment of oncogene-driven non-small cell lung cancer
    Kastelijn, Elisabeth A.
    de Langen, Adrianus J.
    Peters, Bas J. M.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2019, 25 (03) : 300 - 307
  • [7] EGFR: The Paradigm of an Oncogene-Driven Lung Cancer
    Riely, Gregory J.
    Yu, Helena A.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2221 - 2226
  • [8] Targeting Residual Disease in Oncogene-Driven NSCLC
    McCoach, C. E.
    Merrick, D. T.
    Aisner, D. L.
    Bunn, P. A.
    Camdige, D. R.
    Heasley, L. E.
    Doebele, R. C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1546 - S1546
  • [9] Systemic Therapy for Advanced Oncogene-Driven NSCLC
    Gandara, David R.
    Popat, Sanjay
    Melosky, Barbara
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S51 - S52
  • [10] Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
    Vokes, Natalie I.
    Pan, Kelsey
    Le, Xiuning
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15